Journal list menu
Export Citations
Download PDFs
REVIEW ARTICLE
no
How to recognize and manage challenging DRESS cases: Two case reports and a review of the literature
- First Published: 23 August 2022
REVIEW ARTICLE
no
Topical care in pemphigus wounds: A systematic review of the literature
- First Published: 07 September 2022
REVIEW ARTICLE
no
Efficacy and safety of topical brimonidine in dermatology: A review article
- First Published: 12 September 2022
REVIEW ARTICLE
no
Longdan Xiegan formula as adjuvant therapy for acute herpes zoster: A meta-analysis of randomized controlled trials
- First Published: 13 September 2022
REVIEW ARTICLE
no
Hydrogels for localized drug delivery: A special emphasis on dermatologic applications
- First Published: 15 September 2022
REVIEW ARTICLE
no
Noninvasive diagnostic techniques in the preoperative setting of Mohs micrographic surgery: A review of the literature
- First Published: 15 September 2022
REVIEW ARTICLE
no
Complementary and alternative therapies in skin cancer a literature review of biologically active compounds
- First Published: 20 September 2022
REVIEW ARTICLE
no
Off label uses of hyaluronic acid fillers: A review
- First Published: 30 September 2022
ORIGINAL ARTICLE
no
Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study
- First Published: 09 August 2022
ORIGINAL ARTICLE
no
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab
- First Published: 24 August 2022
ORIGINAL ARTICLE
Open Access
oa
Should we be concerned about gastrointestinal-related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real-life study
- First Published: 29 August 2022
ORIGINAL ARTICLE
no
Effect of multifunctional laser photoelectricity platform combined with hydroxychloroquine treatment sensitive facial skin
- First Published: 29 August 2022
ORIGINAL ARTICLE
no
Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study
- First Published: 06 September 2022
ORIGINAL ARTICLE
no
Randomized controlled trial to compare the effectiveness and safety of low dose dexamethasone oral mini-pulse versus diphenylcyclopropenone contact sensitisation in severe pediatric alopecia areata
- First Published: 10 September 2022
ORIGINAL ARTICLE
no
Systemic isotretinoin for acne treatment: Ovarian reserve is safe with the low dose
- First Published: 10 September 2022
ORIGINAL ARTICLE
no
A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine
- First Published: 11 September 2022
ORIGINAL ARTICLE
no
Adverse cutaneous reactions reported post COVID-19 vaccination in Al Buraimi governorate, Sultanate of Oman
- First Published: 13 September 2022
ORIGINAL ARTICLE
no
Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice
- First Published: 16 September 2022
ORIGINAL ARTICLE
no
Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study
- First Published: 13 September 2022
ORIGINAL ARTICLE
no
Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists
- First Published: 15 September 2022
ORIGINAL ARTICLE
no
Predictors of treatment responses of superficial infantile hemangiomas to topical timolol
- First Published: 15 September 2022
ORIGINAL ARTICLE
Open Access
oa
Short-term efficacy and safety of total skin electron beam therapy in mycosis fungoides: Systematic review and meta-analysis
- First Published: 19 September 2022
ORIGINAL ARTICLE
Open Access
oa
Demystifying the mechanism of action of professional facial peeling: In-vivo visualization and quantification of changes in inflammation, melanin and collagen using Vivascope® and ConfoScan®
- First Published: 21 September 2022
ORIGINAL ARTICLE
no
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group
- First Published: 29 September 2022
ORIGINAL ARTICLE
no
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial
- First Published: 28 September 2022
ORIGINAL ARTICLE
Open Access
oa
Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms
- First Published: 30 September 2022
ORIGINAL ARTICLE
Open Access
oa
Monitoring oral propranolol for infantile hemangiomata
- First Published: 30 September 2022
ORIGINAL ARTICLE
no
A randomized, prospective pilot study for comparison of a triple combination of 2940 nm Er:YAG Laser and triamcinolone acetonide solution with either 308 nm excimer laser or 0.1% tacrolimus in treatment of stable segmental vitiligo
- First Published: 30 September 2022
ORIGINAL ARTICLE
no
Efficacy of indwelling trocar therapy for postherpetic neuralgia: A retrospective study of an acupuncture method
- First Published: 01 October 2022
SHORT REPORT
no
Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience
- First Published: 23 August 2022
SHORT REPORT
no
Successful use of anti-IL-23 molecules in overweight-to-obese psoriatic patients: A multicentric retrospective study
- First Published: 29 August 2022
SHORT REPORT
no
Comparative efficacy of intralesional 5 flurouracil and intralesional triamcinolone acetonide in localized plaque psoriasis
- First Published: 30 August 2022
SHORT REPORT
Open Access
oa
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?
- First Published: 05 September 2022
SHORT REPORT
no
Mini pulse corticosteroid therapy with oral dexamethasone for moderate to severe alopecia areata: A multicentric study
- First Published: 07 September 2022
SHORT REPORT
no
A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine
- First Published: 11 September 2022
SHORT REPORT
no
New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: The role of systemic treatments as a possible trigger
- First Published: 11 September 2022
SHORT REPORT
no
Intralesional full-concentration (25 mg/ml) methotrexate in the treatment of plantar warts: A pilot study
- First Published: 13 September 2022
SHORT REPORT
no
Adjuvant nivolumab therapy may not improve disease-free survival in resected acral lentiginous melanoma patients: A retrospective case series
- First Published: 12 September 2022
SHORT REPORT
no
Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab
- First Published: 17 September 2022
SHORT REPORT
Open Access
oa
Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experience
- First Published: 15 September 2022
SHORT REPORT
no
Apremilast and biologics: Characteristics of patients treated with apremilast before, during, or after a biological treatment
- First Published: 19 September 2022
SHORT REPORT
no
Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series
- First Published: 29 September 2022
SHORT REPORT
no
Association between the cumulative dose of cyclosporine and liver enzyme abnormalities in dermatology patients managed with a low-dose regimen
- First Published: 26 September 2022
SHORT REPORT
no
Dramatic response to colchicine treatment in acne fulminans patients with cytological hemophagocytosis: A case series of 12 patients
- First Published: 26 September 2022
SHORT REPORT
no
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real-world case series
- First Published: 26 September 2022
SHORT REPORT
no
Combined therapies in scar treatment—The role of autologous derived agents in scar remodeling: A series of cases
- First Published: 30 September 2022
SHORT REPORT
Open Access
oa
Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study
- First Published: 02 October 2022
SHORT REPORT
no
Synergy of stabilized and nonstabilized hyaluronic acid soft tissue fillers in skin density and skin thickness enhancement
- First Published: 02 October 2022
LETTER
no
Tofacitinib for the treatment of refractory or glucocorticoid-dependent cutaneous leukocytoclastic vasculitis
- First Published: 21 August 2022
LETTER
no
Successful treatment of secukinumab-resistant palmoplantar pustulosis by Dupilumab: A case report
- First Published: 20 August 2022
LETTER
Open Access
oa
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic
- First Published: 26 August 2022
LETTER
Open Access
oa
Two birds with one stone: Successful treatment with methotrexate in a patient with generalized eruptive keratoacanthoma of Grzybowski and rheumatoid arthritis
- First Published: 26 August 2022
LETTER
no
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib
- First Published: 24 August 2022
LETTER
Open Access
oa
Impact of COVID-19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
- First Published: 26 August 2022
LETTER
no
Cold plasma as a potential treatment for parapsoriasis: A case report
- First Published: 26 August 2022
LETTER
no
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID-19 vaccine
- First Published: 27 August 2022
LETTER
no
Erythema multiforme-like drug eruption associated with dupilumab treatment: Report of an unusual case
- First Published: 29 August 2022
Letter
Open Access
oa
Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
- First Published: 29 August 2022
LETTER
Open Access
oa
Transitory hair growth using platelet-rich plasma therapy in stabilized central centrifugal cicatricial alopecia
- First Published: 30 August 2022
LETTER
no
Mepolizumab is highly effective in a rare case of Wells syndrome: Eosinophilic granulomatosis with polyangiitis overlap
- First Published: 31 August 2022
LETTER
Open Access
oa
Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%
- First Published: 06 September 2022
LETTER
no
Ablative 2940 nm Er: YAG fractional laser for male androgenetic alopecia
- First Published: 31 August 2022
Letter
no
Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib
- First Published: 31 August 2022
LETTER
no
Remission of psoriatic arthritis 24 h after adalimumab therapy
- First Published: 07 September 2022
LETTER
no
Lichen planus pigmentosus inversus with nail involvement following COVID-19 vaccination: A case report
- First Published: 10 September 2022
LETTER
no
New onset of pemphigus foliaceus following BBIBP COVID-19 vaccine
- First Published: 12 September 2022
LETTER
no
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement
- First Published: 12 September 2022
LETTER
no
Fat herniation over striae distansea in focal dermal hypoplasia treated with 2940 nm Er:YAG Laser
- First Published: 13 September 2022
LETTER
Open Access
oa
Microneedling as an adjunctive treatment for trichotillomania
- First Published: 13 September 2022
LETTER
Open Access
oa
Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
- First Published: 13 September 2022
LETTER
no
Two cases with new onset of pemphigus foliaceus after SARS-CoV-2 vaccination
- First Published: 16 September 2022
LETTER
no
Atrophic lichen planus post-COVID vaccination in a hepatitis C positive individual
- First Published: 15 September 2022
LETTER
no
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study
- First Published: 15 September 2022
LETTER
no
Guttate psoriasis induced by interferon alfa-2b suppository treatment for high-grade cervical intraepithelial neoplasia
- First Published: 15 September 2022
LETTER
Open Access
oa
Topical finasteride: A potential therapeutic option for hidradenitis suppurativa
- First Published: 17 September 2022
LETTER
Open Access
oa
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
- First Published: 15 September 2022
LETTER
no
Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: A case report
- First Published: 19 September 2022
LETTER
no
A case of pemphigus vulgaris secondary to burns treated successfully by an IL-4 inhibitor
- First Published: 20 September 2022
LETTER
no
Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy
- First Published: 22 September 2022
LETTER
no
Pustular psoriasis appearing in a Chinese woman treated with dupilumab for atopic dermatitis: A case report
- First Published: 24 September 2022
LETTER
no
Wet-wrap therapy combined with compound glycyrrhizin and oral antihistamines as a therapy option for two cases of papuloerythroderma of ofuji
- First Published: 24 September 2022
LETTER
no
Intralesional interleukin-2 augmentation therapy in treatment-refractory melanoma
- First Published: 23 September 2022
LETTER
no
Two is better than one: Effectiveness of dupilumab on atopic dermatitis and chronic rhinosinusitis with nasal polyps in an adolescent
- First Published: 24 September 2022
LETTER
no
A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab
- First Published: 27 September 2022
LETTER
no
A rash election: Partial thickness burns secondary to inadvertent use of indelible voters' ink
- First Published: 27 September 2022
LETTER
no
A Netherton syndrome case report: Response to dupilumab treatment
- First Published: 29 September 2022
LETTER
no
Ixekizumab treatment for drug-induced erythrodermic psoriasis
- First Published: 29 September 2022
LETTER
Open Access
oa
Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide
- First Published: 29 September 2022
LETTER
no
Treatment of papular acantholytic dyskeratosis of vulva with diclofenac sodium 3% gel
- First Published: 29 September 2022
LETTER
no
Intralesional methotrexate is effective in the treatment of recalcitrant lesions of tumor stage mycosis fungoides
- First Published: 01 October 2022
LETTER
no
Baricitinib as an effective treatment for lichen planopilaris
- First Published: 30 September 2022
LETTER
no
A severe case of IgA bullous pemphigoid successfully treated with dupilumab
- First Published: 01 October 2022
LETTER
no
Salicylate poisoning after accidental skin application of salicylic acid in a child
- First Published: 04 October 2022
LETTER
no
Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients
- First Published: 05 October 2022